Moreover, the expression of CSF-1 on tumor cells in melanoma and NSCLC patients correlated with the enrichment of MDSC that could be inhibited in vitro by the blockade of CSF-1/CSF-1R signaling (93). This evidence concerns the gene CSF1R and melanoma.